Your browser doesn't support javascript.
loading
Real-world use of palbociclib monotherapy in retroperitoneal liposarcomas at a large volume sarcoma center.
Nassif, Elise F; Cope, Brandon; Traweek, Raymond; Witt, Russell G; Erstad, Derek J; Scally, Christopher P; Thirasastr, Prapassorn; Zarzour, Maria Alejandra; Ludwig, Joseph; Benjamin, Robert; Bishop, Andrew J; Guadagnolo, B Ashleigh; Ingram, Davis; Wani, Khalida; Wang, Wei-Lien; Lazar, Alexander J; Torres, Keila E; Hunt, Kelly K; Feig, Barry W; Roland, Christina L; Somaiah, Neeta; Keung, Emily Z.
Afiliação
  • Nassif EF; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Cope B; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Traweek R; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Witt RG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Erstad DJ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Scally CP; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Thirasastr P; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Zarzour MA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ludwig J; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Benjamin R; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Bishop AJ; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Guadagnolo BA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ingram D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wani K; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wang WL; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Lazar AJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Torres KE; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Hunt KK; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Feig BW; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Roland CL; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Somaiah N; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Keung EZ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Int J Cancer ; 150(12): 2012-2024, 2022 06 15.
Article em En | MEDLINE | ID: mdl-35128664
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Tecidos Moles / Lipossarcoma Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Tecidos Moles / Lipossarcoma Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article